Healy ALS Trial image

Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis

Sabrina Paganoni, Eric A. Macklin, Suzanne Hendrix, James D. Berry, Michael A. Elliott, Samuel Maiser, Chafic Karam, James B. Caress, Margaret A. Owegi, … David Schoenfeld, and Merit E. Cudkowicz.
The New England Journal of Medicine

January, 2021

Statistical figure from Hyroxycholorquine Clinical Trial showing COVID Outcomes Scale

Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19

Wesley H. Self, Matthew W. Semler, Lindsay M. Leither, … Douglas L. Hayden, … David A. Schoenfeld, … Christine A. Ulysse, … B. Taylor Thompson, Samuel M. Brown, for the National Heart, Lung, and Blood Institute PETAL Clinical Trials Network

December, 2020

Nonconserved Long Intergenic Noncoding RNAs Associate With Complex Cardiometabolic Disease Traits

Andrea S. Foulkes, Caitlin Selvaggi, Tingyi Cao, Marcella E. O’Reilly, Esther Cynn, Puyang Ma, Heidi Lumish, Chenyi Xue, and Muredach P. Reilly.
Arteriosclerosis, Thrombosis, and Vascular Biology

November, 2020

Robust and efficient semi-supervised estimation of average treatment effects with application to electronic health records data

David Cheng, Ashwin N. Ananthakrishnan, and Tianxi Cai.

May, 2020